Latest Regulatory Approvals News

Eureka Group Holdings has acquired the Burrum River Caravan Park on Queensland’s Fraser Coast for $5.3 million, targeting a strategic expansion of long-term rental accommodation amid regional housing pressures and infrastructure growth.

Dateline Resources has gained critical U.S. regulatory approval for its Colosseum Gold-REE Project, unlocking rare earth exploration rights and pursuing an OTCQB listing to engage American investors.

Greenvale Energy has re-engaged Monash University to initiate Liquefaction Test Program 7, aiming to produce bulk samples for high-grade C170 bitumen certification at its Alpha Torbanite Project.

Stanmore Resources has released an updated maiden Reserves Statement for its Isaac Downs Extension metallurgical coal project, confirming 52 million tonnes of Run of Mine coal reserves and a robust +20-year mine life supported by existing infrastructure.

Southern Cross Gold Consolidated Ltd has successfully arranged an upsized C$143 million funding round to fast-track its Sunday Creek Gold-Antimony Project in Victoria, Australia. This capital injection positions the company to advance drilling, underground development, and economic assessments over the coming years.

BlinkLab Limited has raised A$7.66 million through a well-supported placement to accelerate FDA regulatory trials for its autism and ADHD diagnostic platforms, leveraging its innovative smartphone-based technology.

AdAlta Limited has announced a renounceable rights issue to raise up to $1.3 million, aiming to accelerate its ‘East to West’ cellular immunotherapy strategy and explore new strategic options.

Southern Cross Gold Consolidated Ltd has successfully arranged a C$143 million private placement, positioning the company to accelerate development of its Sunday Creek Gold-Antimony Project in Victoria, Australia.

A1 Investments & Resources Limited reported negative operating cash flows and no business activity in Q1 2025, drawing down $200,000 of a $300,000 loan as it seeks a transaction to regain ASX listing status.

Dimerix Limited has announced a US licensing transaction for its Phase 3 asset DMX-200 targeting FSGS, alongside progress updates on its clinical trial. The move underscores the company’s push to address a rare kidney disease with no approved therapies.

Pilot Energy confirms regulatory compliance and operational progress at the Head Field, advancing the repurposing of Cliff Oil infrastructure into a carbon storage facility as part of the Mid West Clean Energy Project.

Imricor Medical Systems has initiated its first MRI-guided atrial flutter ablation procedures at Semmelweis University in Budapest, marking a significant expansion of its real-time MRI technology in Europe.